Schaffler H, Breitruck A (2018) Clostridium difficile - from colonization to infection. Front Microbiol 9:646

Article  PubMed  PubMed Central  Google Scholar 

Moore SC (2018) Clostridium difficile: more challenging than ever. Crit Care Nurs Clin North Am 30(1):41–53

Article  PubMed  Google Scholar 

Bouza E, Cobo J, Almirante B, Grupo de Trabajo C (2019) Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile. Rev Esp Quimioter 32(1):50–9

PubMed  PubMed Central  CAS  Google Scholar 

Song JH, Kim YS (2019) Recurrent Clostridium difficile infection: risk factors, treatment, and prevention. Gut Liver 13(1):16–24

Article  PubMed  CAS  Google Scholar 

Esteban-Vasallo MD, de Miguel-Diez J, Lopez-de-Andres A, Hernandez-Barrera V, Jimenez-Garcia R (2019) Clostridium difficile-related hospitalizations and risk factors for in-hospital mortality in Spain between 2001 and 2015. J Hosp Infect 102(2):148–156

Article  PubMed  CAS  Google Scholar 

Kelly CP (2012) Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 18(Suppl 6):21–27

Article  PubMed  Google Scholar 

Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38(6):2386–2388

Article  PubMed  PubMed Central  CAS  Google Scholar 

Johnson S, Lavergne V, Skinner AM et al (2021) Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis 73(5):755–757

Article  PubMed  Google Scholar 

van Prehn J, Reigadas E, Vogelzang EH et al (2021) European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 27(Suppl 2):S1–S21

Article  PubMed  Google Scholar 

Reigadas E, van Prehn J, Falcone M et al (2021) How to: prophylactic interventions for prevention of Clostridioides difficile infection. Clin Microbiol Infect 27(12):1777–1783

Article  PubMed  Google Scholar 

Barbut F, Gouot C, Lapidus N et al (2017) Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case-control study. Eur J Clin Microbiol Infect Dis 36(12):2423–2430

Article  PubMed  CAS  Google Scholar 

Abou Chakra CN, Pepin J, Valiquette L (2012) Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS ONE 7(1):e30258

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gallo A, Vallone C, Sabatelli L et al (2018) Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol 53(5):567–572

Article  PubMed  CAS  Google Scholar 

Kim J, Kim H, Oh HJ et al (2017) Fecal calprotectin level reflects the severity of Clostridium difficile infection. Ann Lab Med 37(1):53–57

Article  PubMed  CAS  Google Scholar 

Boone JH, DiPersio JR, Tan MJ et al (2013) Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection. Eur J Clin Microbiol Infect Dis 32(12):1517–1523

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wen BJ, Te LG, Liu XX, Zhao JH (2022) The value of fecal calprotectin in Clostridioides difficile infection: a systematic review. Front Physiol 13:881816

Article  PubMed  PubMed Central  Google Scholar 

Origuen J, Corbella L, Orellana MA et al (2018) Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test. Clin Microbiol Infect 24(4):414–421

Article  PubMed  CAS  Google Scholar 

Origuen J, Orellana MA, Fernandez-Ruiz M et al (2019) Toxin B PCR amplification cycle threshold adds little to clinical variables for predicting outcomes in Clostridium difficile infection: a retrospective cohort study. J Clin Microbiol 57(2):e01125-18

Bagdasarian N, Rao K, Malani PN (2015) Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA 313(4):398–408

Article  PubMed  PubMed Central  Google Scholar 

McDonald LC, Gerding DN, Johnson S et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66(7):987–994

Article  PubMed  CAS  Google Scholar 

Cohen SH, Gerding DN, Johnson S et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431–455

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

Article  PubMed  CAS  Google Scholar 

Orellana-Miguel MA, Alcolea-Medina A, Barrado-Blanco L, Rodriguez-Otero J, Chaves-Sanchez F (2013) Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection. Enferm Infecc Microbiol Clin 31(2):97–99

Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32–35

Article  PubMed  CAS  Google Scholar 

Brandtzaeg P, Gabrielsen TO, Dale I, Muller F, Steinbakk M, Fagerhol MK (1995) The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 371A:201–206

Article  PubMed  CAS  Google Scholar 

Sanchez L, Calvo M, Brock JH (1992) Biological role of lactoferrin. Arch Dis Child 67(5):657–661

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zar FA, Bakkanagari SR, Moorthi KM, Davis MB (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45(3):302–307

Article  PubMed  CAS  Google Scholar 

Perry DA, Shirley D, Micic D et al (2022) External validation and comparison of Clostridioides difficile severity scoring systems. Clin Infect Dis 74(11):2028–2035

Article  PubMed  Google Scholar 

Swale A, Miyajima F, Roberts P et al (2014) Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study. PLoS ONE 9(8):e106118

Article  PubMed  PubMed Central  Google Scholar 

Suarez-Carantona C, Rodriguez-Torres A, Viteri-Noel A et al (2021) Usefulness of fecal calprotectin in the management of patients with toxigenic Clostridioides difficile. J Clin Med 10(8):1627

Rao K, Malani PN (2020) Diagnosis and treatment of Clostridioides (Clostridium) difficile infection in adults in 2020. JAMA 323(14):1403–1404

Article  PubMed  Google Scholar 

Ofori E, Ramai D, Dhawan M, Mustafa F, Gasperino J, Reddy M (2018) Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect 99(4):436–442

Article  PubMed  CAS  Google Scholar 

Ooijevaar RE, van Beurden YH, Terveer EM et al (2018) Update of treatment algorithms for Clostridium difficile infection. Clin Microbiol Infect 24(5):452–462

Article  PubMed  CAS  Google Scholar 

El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB (2013) Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 56(12):1713–1721

Article  PubMed  PubMed Central  Google Scholar 

Gateau C, Couturier J, Coia J, Barbut F (2018) How to: diagnose infection caused by Clostridium difficile. Clin Microbiol Infect 24(5):463–468

Article  PubMed  CAS  Google Scholar 

LaSala PR, Ekhmimi T, Hill AK, Farooqi I, Perrotta PL (2013) Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens. J Clin Microbiol 51(1):311–313

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wilcox MH, Gerding DN, Poxton IR et al (2017) Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 376(4):305–317

Article  PubMed  CAS  Google Scholar 

van Nood E, Vrieze A, Nieuwdorp M et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407–415

Article  PubMed  Google Scholar 

Pawlowski SW, Warren CA, Guerrant R (2009) Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology 136(6):1874–1886

Article  PubMed  CAS